Purpose

This study will compare and determine the most ideal local anesthetic (LA) solution to activate a labor epidural: lidocaine, bupivacaine, or a combination of bupivacaine plus lidocaine.

Condition

Eligibility

Eligible Ages
Between 19 Years and 60 Years
Eligible Genders
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Pregnant patients over the age of 19 who are scheduled for an induction of labor and request an epidural are eligible for the study

Exclusion Criteria

  • age <19 - allergy to the drug or drug class - preexisting neuropathy - history of back pain prior to pregnancy or history of back surgery - history of chronic opioid use - history of hypertension or hypertensive disorders of pregnancy - congenital or acquired cardiac disease - contraindication to epidural placement (patient refusal, severe coagulopathy, infection at site of epidural needle insertion, severe hypovolemia)

Study Design

Phase
Phase 3
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Prevention
Masking
Triple (Participant, Care Provider, Investigator)

Arm Groups

ArmDescriptionAssigned Intervention
Active Comparator
1% Lidocaine
Patients randomized into the lidocaine group will receive 10 mL of 1% lidocaine
  • Drug: 1% Lidocaine
    10 mL of 1% lidocaine
    Other names:
    • Lidoderm, Xylocaine, Recticare, Anecream,
    • Solarcaine, Anestacon, Cutiecaine, Lidocoll,
Active Comparator
0.25% Bupivacaine
Patients randomized into the bupivacaine group will receive 10 mL of 0.25% bupivacaine
  • Drug: 0.25% Bupivacaine
    10 mL of 0.25% bupivacaine
    Other names:
    • Marcaine and Sensorcaine
Active Comparator
Bupivacaine plus Lidocaine
Patients randomized into the bupivacaine group will receive 5 mL of 0.25% bupivacaine and 5 mL of 1% lidocaine.
  • Drug: Bupivacaine plus Lidocaine
    5 mL of 1% lidocaine and 5 mL of 0.25% bupivacaine
    Other names:
    • Lidoderm, Xylocaine, Recticare, Anecream, Lmx4, Akten,
    • Marcaine and Sensorcaine

More Details

Status
Completed
Sponsor
University of Alabama at Birmingham

Study Contact

Detailed Description

The most common and effective method for controlling labor pains is a local anesthetic (LA) infusion through a lumbar epidural. To achieve adequate pain control during the first stage of labor - onset of contractions to complete cervical dilation - nerve fibers up to the T10 dermatome must be anesthetized. When a patient is in active labor and an epidural catheter is placed, the anesthesiologist must activate the epidural by administering LA through the epidural to promote spread of the LA in the epidural space to anesthetize the nerve fibers involved in the conduction of labor pains. The ideal LA to achieve this goal is one that would allow for the fastest onset to achieve quick pain relief with the fewest side effects. Two commonly used LA to provide labor analgesia are bupivacaine and lidocaine. When low concentrations - 0.25% bupivacaine and 1% lidocaine - are used for labor analgesia, both of these LA can be administered safely with very little concern of major adverse effects associated with LA toxicity. Given that there is limited and conflicting evidence for the usefulness of the bupivacaine and lidocaine mixture especially as it relates to labor epidural activation, we hope to readdress these questions in an effort to determine whether or not the LA combination offers any distinct advantage over the individual LA. The investigators intend to determine the time it takes to achieve an adequate level (T10) for labor analgesia, the total spread of local anesthetic, and the degree of motor block as these factors will be important in determining the most optimal LA solution to activate a labor epidural. With the results from this study, the investigators hope to recommend a LA solution that will allow for the fastest pain relief in the laboring mother with the fewest side effects.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.